Exciting Deals Just for You! Check Out Our Specials Here!

FAQ’s

Frequently Asked Questions

Semaglutide FAQ's

  • Weight loss varies person to person. In one medical study 1,961 adults living with obesity/overweight with a medical problem found that adults taking Semaglutide lost an average of 35 pounds (or 15% body weight). Adults receiving placebo lost an average of 6 pounds (or 2.5% body weight).
  • Weight loss is maximized and sustained with improved diet and increased activity/exercise.
  • This medication effects everyone differently, but if you do experience side effects it’s usually gastrointestinal; including, nausea, diarrhea, or vomiting. For most patients, these side effects are mild and improve over time. Personalized dose adjustments can assist with limiting side effects as well.
  • Like most medications, rare cases of angioedema and anaphylaxis have occurred.
  • Semaglutide is administered once a week via subcutaneous injection in the abdomen, thigh, or upper arm.
  • Semaglutide is administered on the same day of the week, any time of day, with or without meals.

If you miss a dose or the day of the week needs to be changed you can change the day as long as your last dose was 2 or more days before (>48 hours).

  • Typically, insurance company’s do not cover this treatment, but we recommend you contact your insurance company to see if it’s covered.
  • We have forms that you can fill out and submit to your insurance company for potential reimbursement.
  • Dispose of needles in sharps container or detergent bottle labeled “sharps”. Contact local health department for sharps drop off locations near you.
  • List of local sharps drop off locations:

https://wisconsindnr.shinyapps.io/sharpscollectorsite/

Yes, Semaglutide can reduce the risk of cardiovascular and kidney disease.

Contraindications include pregnancy, breast feeding, pancreatitis, personal or family history of medullary thyroid cancer, or multiple endocrine neoplasia 2A or 2B.

Tirzepatide FAQ's

Tirzepatide may be recommended for individuals who are overweight or obese and have struggled to lose weight through diet and exercise alone. It is typically prescribed for adults with a BMI of 27 kg/m² or higher who have at least one weight-related health condition, such as type 2 diabetes or high blood pressure.

Tirzepatide is usually administered once a week via subcutaneous injection. Your healthcare provider will determine the appropriate dosage and frequency based on your individual needs and response to treatment.

Common side effects of Tirzepatide may include nausea, vomiting, diarrhea, abdominal discomfort, and decreased appetite. These side effects often improve over time as your body adjusts to the medication. However, it’s essential to report any persistent or severe side effects to your healthcare provider.

Tirzepatide is most effective when used as part of a comprehensive weight loss program that includes dietary changes, exercise, and behavioral support. It is not intended to be used as a standalone treatment for weight loss.

Weight loss results with Tirzepatide can vary depending on individual factors such as starting weight, adherence to the treatment plan, and lifestyle habits. Some people may start to notice weight loss within a few weeks of starting treatment, while others may require several months to see significant changes.

Tirzepatide is generally safe and well-tolerated for long-term use in clinical trials. However, as with any medication, it’s essential to discuss the risks and benefits with your healthcare provider, especially if you have any pre-existing medical conditions or concerns.

Your healthcare provider will advise you on the appropriate duration of Tirzepatide treatment based on your individual circumstances. It’s essential to follow their guidance and not discontinue the medication abruptly without consulting them, as this could affect your weight maintenance and overall health.

Invisa-RED FAQ's

Low-light laser energy is part of the range of electromagnetic rays that are necessary for metabolism and growth in human beings. It is also part of the natural light spectrum of sunlight, minus the skin-damaging UV rays, which is why NASA currently uses this type of energy in space. It is also vibration energy, with which the human body resonates. This is the reason that it can penetrate through the skin.

Sunlight is a combination of visible, UV, and infrared light. Red laser light is longer in wavelength than visible light and starts just after the visible color of red. Red laser light is the safest and healthiest spectrum of sunlight. Red laser light from the sun accounts for 70% of the heating of the Earth, the rest being caused by visible light. It is, therefore, understood that a good combination of visible light and red laser light offers the most benefits in the electromagnetic heating of objects that absorb infrared light, such as the human body. Other forms of heat, such as fire and ceramic heaters, warm a person by heating the surrounding air that touches the person, which does not penetrate deeply into the body. Red laser light heat penetrates the skin and is much more effective. Certain red laser light wavelengths also interact with living cells, increasing metabolism and energy production and causing more fuel (calories) to be burned.

LLLT produces red and infrared light at specific frequencies (650nm – 940nm). The human cells have light-sensitive chemicals, called chromophores, which react to light in the 600nm – 900nm range. When stimulated by energy in this range, the cells produce more ATP, which is the energy source that powers every muscle and increases metabolism. Red laser light also causes DNA synthesis in the fibroblasts of the cells, which makes the skin more elastic and younger-looking. In addition, near-infrared light promotes cellular healing, thus reducing the recovery time after a workout. LLLT is used without exercise while relaxing and is very effective in heating the body. invisa-RED™ accelerates the body’s natural detoxification processes.

LLLT, in a similar fashion, has been used in Europe and Asia since 1999. It is only now catching on in North America.

Invisa-RED is not recommended for individuals who are pregnant, breastfeeding, or have a history of skin cancers. Additionally, those with implanted medical devices, heart conditions, photosensitive or other significant skin conditions, and insulin-dependent diabetes should consult a healthcare professional before treatment. Always discuss your medical history and concerns with your provider to ensure safety.